| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/APPI.AJP.159.11.1862 |
| P698 | PubMed publication ID | 12411220 |
| P2093 | author name string | Mark Sullivan | |
| James D Bowen | |||
| Laura E Gibbons | |||
| George H Kraft | |||
| Dawn M Ehde | |||
| Lydia Chwastiak | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 1862-1868 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample | |
| P478 | volume | 159 |
| Q36204401 | A Disproportionate Burden of Care: Gender Differences in Mental Health, Health-Related Quality of Life, and Social Support in Mexican Multiple Sclerosis Caregivers |
| Q90004899 | A complex relation between depression and multiple sclerosis: a descriptive review |
| Q36347795 | A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol |
| Q92632973 | A new way of rapidly screening for depression in multiple sclerosis using Emotional Thermometers |
| Q35932063 | A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model |
| Q36227300 | A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence |
| Q35181841 | A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview |
| Q39121124 | Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience |
| Q26778897 | Assessing Nociception by fMRI of the Human Spinal Cord: A Systematic Review |
| Q49046491 | Assessment Of Depression In Multiple Sclerosis: Development Of A “Trunk And Branch” Model |
| Q35231633 | Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C |
| Q93271339 | Behavioral Interventions in Multiple Sclerosis |
| Q36090177 | Body image mediates the depressive effects of weight gain in new mothers, particularly for women already obese: evidence from the Norwegian Mother and Child Cohort Study |
| Q48159747 | Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study |
| Q34919107 | Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients |
| Q37442448 | Clinical management of multiple sclerosis through home telehealth monitoring: results of a pilot project |
| Q33746881 | Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study |
| Q37379245 | Co-occurring depression and pain in multiple sclerosis |
| Q33760818 | Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis |
| Q92778465 | Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active compa |
| Q48527817 | Confirmatory factor structure of the Center for Epidemiologic Studies-Depression scale (CES-D) in mild-to-moderate traumatic brain injury. |
| Q47634719 | Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance |
| Q36626879 | Cross-Sectional Examination of the Associations Between Symptoms, Community Integration, and Mental Health in Multiple Sclerosis |
| Q38611076 | Depression and Age at First Neurology Appointment Associated with Receipt of Behavioral Medicine Services Within 1 Year in a Multiple Sclerosis Population |
| Q36764298 | Depression and immunity: inflammation and depressive symptoms in multiple sclerosis |
| Q42714313 | Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness |
| Q37382124 | Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue |
| Q50107697 | Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment |
| Q47693163 | Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it. |
| Q83209510 | Depression in focal, segmental and generalized dystonia |
| Q36585597 | Depression in multiple sclerosis: a longitudinal analysis |
| Q24670409 | Depression in multiple sclerosis: a review |
| Q36337359 | Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations |
| Q37258747 | Depression in multiple sclerosis: review and theoretical proposal |
| Q22306498 | Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke |
| Q36134388 | Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory. |
| Q37107165 | Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling |
| Q35114661 | Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: description and outcomes |
| Q33573208 | Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis |
| Q26782370 | Electroconvulsive Therapy in Multiple Sclerosis |
| Q36502629 | Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? |
| Q37330915 | Emotional change-associated T cell mobilization at the early stage of a mouse model of multiple sclerosis |
| Q89999379 | Epidemiology and treatment of multiple sclerosis in elderly populations |
| Q47130980 | Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data |
| Q34980458 | Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study |
| Q37509398 | Factors associated with adaptation to Klinefelter syndrome: the experience of adolescents and adults |
| Q53198617 | High concurrent presence of disability in multiple sclerosis. Associations with perceived health. |
| Q48074885 | Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression. |
| Q36460699 | Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. |
| Q58795499 | Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions |
| Q30961081 | Is major depression a neurologic disorder with psychiatric symptoms? |
| Q46413066 | Is religious coping related to better quality of life following acute myocardial infarction? |
| Q37608614 | Longitudinal study of alexithymia and multiple sclerosis |
| Q47642142 | Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity |
| Q37107342 | Managing complex problems: treatment for common mental disorders in the UK. |
| Q37346233 | Measuring participation in people living with multiple sclerosis: a comparison of self-reported frequency, importance and self-efficacy |
| Q34006944 | Melatonin acts as antioxidant and improves sleep in MS patients. |
| Q30241221 | Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder |
| Q51909464 | Mental health problems in children of somatically ill parents, e.g. multiple sclerosis. |
| Q38243321 | Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease: a review of randomized clinical trials |
| Q63285840 | Multiple Sclerosis and Bipolar Disorders |
| Q50761855 | Negative affect predicts subsequent cognitive change in multiple sclerosis. |
| Q26778311 | Neurobehavioral burden of multiple sclerosis with nanotheranostics |
| Q81957990 | Neuropsychiatric manifestations of multiple sclerosis |
| Q35146090 | Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis |
| Q36816738 | Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia |
| Q48105215 | Perceived cognitive difficulties and cognitive test performance as predictors of employment outcomes in people with multiple sclerosis |
| Q34083645 | Physical disability, anxiety and depression in people with MS: an internet-based survey via the UK MS Register |
| Q37771075 | Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment |
| Q113506434 | Predicting states of elevated negative affect in adolescents from smartphone sensors: a novel personalized machine learning approach |
| Q35117418 | Predictors of anxiety in multiple sclerosis |
| Q35787267 | Prevalence and influence factors of suicidal ideation among females and males in Northwestern urban China: a population-based epidemiological study. |
| Q35523332 | Prevalence and psychosocial correlates of depressive symptoms among adolescents and adults with Klinefelter syndrome |
| Q36086116 | Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran |
| Q35882486 | Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study |
| Q41033035 | Progressive multiple sclerosis and mood disorders. |
| Q33495766 | Protocol for the saMS trial (supportive adjustment for multiple sclerosis): a randomized controlled trial comparing cognitive behavioral therapy to supportive listening for adjustment to multiple sclerosis |
| Q57244178 | Psychiatric comorbidity is associated with disability progression in multiple sclerosis |
| Q28541642 | Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study |
| Q36972200 | Psychiatric issues in multiple sclerosis |
| Q41833813 | Psychiatric morbidity in patients with transverse myelitis and stroke: A comparison. |
| Q98160261 | Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? |
| Q24202884 | Psychological interventions for depression in adolescent and adult congenital heart disease |
| Q24248059 | Psychological interventions for depression in adolescent and adult congenital heart disease |
| Q36209995 | Psychological well-being in people with multiple sclerosis in an Iranian population |
| Q28301691 | Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment |
| Q33864809 | Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis |
| Q36821057 | Relationships among depressive symptoms, benefit-finding, optimism, and positive affect in multiple sclerosis patients after psychotherapy for depression. |
| Q38885617 | Role of Inflammation in Suicide: From Mechanisms to Treatment |
| Q88983835 | Salivary biomarkers for the diagnosis and monitoring of neurological diseases |
| Q35309265 | Social characteristics and quality of life of portuguese multiple sclerosis patients |
| Q55109364 | Somatic Symptoms of Depression and Anxiety in People with Multiple Sclerosis. |
| Q48509763 | Symptom management in patients with multiple sclerosis |
| Q35018491 | Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice |
| Q90578818 | The Effect of Repetitive Transcranial Magnetic Stimulation on Spasticity in Patients with Multiple Sclerosis |
| Q47165616 | The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial. |
| Q49499789 | The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series |
| Q94601958 | The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients |
| Q36481033 | The association of depression with pain-related treatment utilization in patients with multiple sclerosis |
| Q50909003 | The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. |
| Q35742954 | The co-occurrence of pain and depression in adults with multiple sclerosis |
| Q35891823 | The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial |
| Q92757080 | The evaluation of an online mindfulness program for people with multiple sclerosis: study protocol |
| Q35573292 | The impact of mood disorders in neurological diseases: should neurologists be concerned? |
| Q34457934 | The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review |
| Q38238940 | The link between multiple sclerosis and depression |
| Q34056620 | The relevance of depressive symptoms and social support to disability in women with multiple sclerosis or fibromyalgia |
| Q31096449 | The role of basic health insurance on depression: an epidemiological cohort study of a randomized community sample in northwest China |
| Q26800426 | The role of inflammation in suicidal behaviour |
| Q37629581 | The spectrum of psychosis in multiple sclerosis: a clinical case series |
| Q47609976 | The stress-buffering effects of hope on adjustment to multiple sclerosis. |
| Q36372996 | The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: Important targets for intervention. |
| Q46007358 | Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. |
| Q34482196 | Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson’s disease |
| Q45375629 | Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis |
| Q46232816 | Unique relations between post-traumatic stress disorder symptoms and patient functioning in type 2 diabetes. |
| Q63952693 | Unrecognised symptoms of depression in a community–based population with multiple sclerosis |
| Q35001445 | Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study |
| Q38946444 | Using the Center for Epidemiologic Studies Depression Scale to Assess Depression in Women With HIV and Women at Risk for HIV: Are Somatic Items Invariant? |
| Q35732722 | Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey |
| Q36654417 | Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study |
| Q45138514 | Variations in functioning and disability in multiple sclerosis. A two-year prospective study |
| Q75212722 | When did neurologists and psychiatrists stop talking to each other? |
| Q80855586 | [Adherence to neurologic treatment. Lessons from multiple sclerosis] |
| Q87907439 | [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice] |
| Q83636839 | [Depression in multiple sclerosis] |
| Q82689687 | [Dermatosis and depressive symptoms] |
Search more.